STOCK TITAN

Cyclerion Therapeutics, Inc. (CYCN) Free Cash Flow by Year

CYCN

Cyclerion Therapeutics, Inc. does not report free cash flow for fiscal year 2025, so the figure is not reported on this page. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Cyclerion Therapeutics, Inc. has filed alongside them.

FY2025 annual
Free Cash Flow N/A
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

CYCN Free Cash Flow by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25S-4/AFY24S-4/AFY2310-K/AFY2210-KFY2110-KFY2010-KFY1910-KFY1810-K
Free Cash FlowN/AN/AN/A-$40.6M-11.2%-$36.5M+50.7%-$74.0M+32.2%-$109.1MN/A

CYCN Free Cash Flow by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'26S-4/AQ4'2510-QQ3'2510-QQ2'2510-QQ1'25S-4/AQ4'24S-4/AQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K/AQ3'2310-Q
Free Cash Flow-$1.4M-184.7%-$1.2M-28.3%N/AN/A-$503K-$968KN/AN/AN/AN/AN/AN/A

What free cash flow means

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper.

More Cyclerion Therapeutics, Inc. financials

Frequently Asked Questions

What was Cyclerion Therapeutics, Inc.'s free cash flow in fiscal year 2025?

Cyclerion Therapeutics, Inc. does not report free cash flow for fiscal year 2025, so the figure is not reported on this page.

What was Cyclerion Therapeutics, Inc.'s free cash flow in the most recent quarter?

Cyclerion Therapeutics, Inc. (CYCN) reported -$1.4M in free cash flow in Q2 2026. This represents a decrease of 184.7% from the same quarter a year earlier.

What does free cash flow mean on a financial statement?

Free cash flow is the cash operations produced over the period, less what the company spent on property, plant and equipment, so it answers what was left over rather than what was earned on paper. This page lists what Cyclerion Therapeutics, Inc. (CYCN) reported on that line in every period on record.